Vivo Bio Tech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 7 February 2025.Powered by Capital Market - Live News

Net profit of Vivo Bio Tech declined 37.88% to Rs 0.82 crore in the quarter ended December 2024 as against Rs 1.32 crore during the previous quarter ended December 2023. Sales declined 4.98% to Rs 12.21 crore in the quarter ended December 2024 as against Rs 12.85 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.2112.85 -5 OPM %45.3749.65 - PBDT3.714.18 -11 PBT1.461.91 -24 NP0.821.32 -38 Powered by Capital Market - Live News

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 9 January 2025.Powered by Capital Market - Live News

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 21 November 2024Powered by Capital Market - Live News

Net profit of Vivo Bio Tech rose 1484.85% to Rs 5.23 crore in the quarter ended September 2024 as against Rs 0.33 crore during the previous quarter ended September 2023. Sales rose 30.02% to Rs 12.04 crore in the quarter ended September 2024 as against Rs 9.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.049.26 30 OPM %46.4352.48 - PBDT8.162.77 195 PBT5.870.46 1176 NP5.230.33 1485 Powered by Capital Market - Live News